BTV is a member of the Orbivirus genus, which also includes African horse sickness virus (AHSV) and epizootic hemorrhagic disease virus (EHDV). These viruses are transmitted by biting midges and can cause significant economic losses in livestock.
The new study, published in the journal Nature Communications, focused on the BTV fusion protein, which is essential for the virus to enter host cells. The team used cryo-electron microscopy to determine the structure of the fusion protein in its prefusion form, which is the state in which it exists on the surface of the virus particle.
The structure revealed that the fusion protein is composed of two subunits, each of which contains a hydrophobic fusion peptide. These peptides are normally buried within the protein, but upon contact with the host cell membrane, they are released and insert themselves into the membrane, causing the viral and cellular membranes to fuse. This fusion process allows the viral genome to enter the host cell, where it can replicate and produce new virus particles.
The new structural information provides a detailed understanding of how the BTV fusion protein works, which could aid in the development of new antiviral therapies. For example, it may be possible to design drugs that block the fusion process, thereby preventing the virus from entering host cells.
The study also has implications for the development of vaccines against BTV. By understanding the structure of the fusion protein, scientists may be able to design vaccines that elicit antibodies that specifically target the fusion peptide, thereby neutralizing the virus.
"This new structural information provides important insights into how bluetongue virus enters host cells," said Dr. Joel Grimes, head of the Structural Virology group at The Pirbright Institute. "This knowledge could lead to the development of new antiviral therapies and vaccines, which would be a significant benefit to livestock farmers around the world."
Bluetongue virus is a major economic threat to the livestock industry, causing significant losses in animal production and trade. The development of new antiviral therapies and vaccines would help to protect livestock from this devastating disease.
